If you have symptoms of fever, cough or difficulty breathing, have traveled to areas impacted by the Coronavirus (2019-nCoV) within the past 14 days, and/or have been in close contact with someone who has traveled outside the US or been exposed to the Coronavirus please call your primary clinic before coming in for your appointment. We have also made temporary changes to who may accompany patients to appointments and treatments. Learn More

About Us

NCI News

NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
2/24/2021

A prior infection with SARS-CoV-2, the virus that causes COVID-19, appears to protect, at least for a few months, against reinfection from the virus, according to an NCI study. The finding may have important public health implications.


Fecal microbiota transplants help patients with advanced melanoma respond to immunotherapy
2/04/2021

For patients with cancers that do not respond to immunotherapy drugs, the use of fecal transplants to modify the gut microbiome may help some of these patients respond to the immunotherapy drugs.


Some postmenopausal women with breast cancer may forgo chemotherapy
12/09/2020

Some postmenopausal women with HR-positive, HER2-negative breast cancer may not benefit from chemotherapy and can safely forgo the treatment, according to clinical trial results presented at the San Antonio Breast Cancer Symposium.


Study of “exceptional responders” yields clues to cancer and potential treatments
11/19/2020

A comprehensive analysis of patients with cancer who had exceptional responses to therapy has revealed molecular changes in the patients’ tumors that may explain some of the exceptional responses.


NCI, NIBIB award contracts to develop innovative digital health technologies for COVID-19
9/15/2020

NCI and the National Institute of Biomedical Imaging and Bioengineering have awarded seven contracts to develop digital health solutions, like smartphone apps, wearable devices, and software, that help address the COVID-19 pandemic.


NCI, Cancer Research UK launch Cancer Grand Challenges partnership to support bold new ideas for cancer research
8/27/2020

NCI and Cancer Research UK will partner to fund Cancer Grand Challenges, an international initiative to address profound and unanswered questions in cancer research.


New treatments spur sharp reduction in lung cancer mortality rate
8/12/2020

Mortality rates from the most common lung cancer, non-small cell lung cancer (NSCLC), have fallen sharply in the United States in recent years, due primarily to recent advances in treatment, an NCI study shows.


AI dual-stain approach improved accuracy, efficiency of cervical cancer screening in NCI study
6/25/2020

In a new study, an automated dual-stain method using artificial intelligence improved the accuracy and efficiency of cervical cancer screening compared with the current standard for follow-up of women who test positive with primary HPV screening.


NIH scientists develop blood test to help improve liver cancer screening
6/11/2020

The new test is relatively simple and could improve screening for people who are at risk for developing hepatocellular carcinoma (HCC), the most common form of liver cancer. It could help doctors find and treat HCC early.


Study identifies potential approach to treat severe respiratory distress in patients with COVID-19
6/05/2020

As described in an NCI Media Availability, early data from a clinical study suggest that treatment with the cancer drug acalabrutinib provided clinical benefit to a small group of patients with severe COVID-19.